List of Omidria drug patents
Omidria is owned by Rayner Surgical.
Omidria contains Ketorolac Tromethamine; Phenylephrine Hydrochloride.
Omidria has a total of 13 drug patents out of which 0 drug patents have expired.
Omidria was authorised for market use on 30 May, 2014.
Omidria is available in solution;irrigation dosage forms.
Omidria can be used as maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain.
The generics of Omidria are possible to be released after 23 April, 2034.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9399040 | RAYNER SURGICAL | Ophthalmologic irrigation solutions and method |
Jul, 2023
(5 months from now) | |
| US8173707 | RAYNER SURGICAL | Ophthalmologic irrigation solutions and method |
Jul, 2023
(5 months from now) | |
| US9278101 | RAYNER SURGICAL | Ophthalmologic irrigation solutions and method |
Jul, 2023
(5 months from now) | |
| US8586633 | RAYNER SURGICAL | Ophthalmologic irrigation solutions and method |
Jul, 2023
(5 months from now) | |
|
US9399040
(Pediatric) | RAYNER SURGICAL | Ophthalmologic irrigation solutions and method |
Jan, 2024
(11 months from now) | |
|
US8173707
(Pediatric) | RAYNER SURGICAL | Ophthalmologic irrigation solutions and method |
Jan, 2024
(11 months from now) | |
|
US8586633
(Pediatric) | RAYNER SURGICAL | Ophthalmologic irrigation solutions and method |
Jan, 2024
(11 months from now) | |
|
US9278101
(Pediatric) | RAYNER SURGICAL | Ophthalmologic irrigation solutions and method |
Jan, 2024
(11 months from now) | |
| US9486406 | RAYNER SURGICAL | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
Oct, 2033
(10 years from now) | |
| US9066856 | RAYNER SURGICAL | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
Oct, 2033
(10 years from now) | |
| US9855246 | RAYNER SURGICAL | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
Oct, 2033
(10 years from now) | |
|
US9486406
(Pediatric) | RAYNER SURGICAL | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
Apr, 2034
(11 years from now) | |
|
US9066856
(Pediatric) | RAYNER SURGICAL | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
Apr, 2034
(11 years from now) | |
Drugs and Companies using KETOROLAC TROMETHAMINE; PHENYLEPHRINE HYDROCHLORIDE ingredient
Market Authorisation Date: 30 May, 2014
Treatment: Maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain
Dosage: SOLUTION;IRRIGATION
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic